mRNA Technology - Search News

FDA committee unanimously recommends 1st mRNA flu vaccine

FDA panel backs first-of-its-kind flu vaccine using mRNA technology

A new kind of flu vaccine has moved a step closer to the U.S. market as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ending the COVID-19...

· 3d

Future flu seasons may look different thanks to mRNA technology. Find out why.

· 3d

Moderna mRNA Flu Vaccine Wins FDA Advisory Committee Backing

· 2d

Moderna's mRNA flu vaccine backed by FDA advisers

Advisers to the U.S. Food and Drug Administration on Thursday backed approval of Moderna's (MRNA.O) flu vaccine for adults aged ‌50 and older, saying its benefits outweigh its risks, boosting the comp...

· 2d

FDA panel recommends mRNA flu vaccine for older adults

· 2d

FDA panel recommends Moderna’s mRNA flu shot for older adults

Moderna just got a signal investors can’t ignore

Moderna (MRNA) has been struggling to shake one label for years: Covid winner. That label helped to make the company famous, but it also became a problem for the stock when pandemic demand dropped and investors questioned whether Moderna could develop a stable business beyond one historic product

6don MSN

mRNA flu vaccine offers immune protection against diverse strains

A new study led by researchers at Washington University School of Medicine in St. Louis has found that an investigational mRNA influenza vaccine helps the immune system recognize a wider range of influenza viruses than today's standard flu shot,

12don MSN

Cancer vaccines based on mRNA advance, despite US cuts

By Julie Steenhuysen CHICAGO, June 9 (Reuters) - Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting benefit against the deadly skin cancer melanoma and early promise in pancreatic and brain cancers once considered impervious to immune system assault.